OA03.05 A Randomized, Phase 3 Study of Iruplinalkib (WX-0593) vs Crizotinib in Locally Advanced or Metastatic ALK+ Non-small Cell Lung Cancer (NSCLC).

Details

Language :

English

ISSN :

15560864

Volume :

18

Issue :

11

Database :

Complementary Index

Journal :

Journal of Thoracic Oncology

Publication Type :

Academic Journal

Accession number :

173322631

Full Text :

https://doi.org/10.1016/j.jtho.2023.09.034